In Vivo Nanotoxicity Testing using the Zebrafish Embryo Assay

Area of Science:

• Biomedical Engineering
• Toxicology
• Developmental Biology

Background:

• Nanoparticles are widely used in biomedical applications for diagnostics and therapeutics.
• Concerns about the long-term safety and toxicological impact of novel nanomaterials necessitate efficient nanotoxicity testing methods.
• Current testing methods include cell-based assays and animal studies, which have limitations in complexity, cost, or invasiveness.

Purpose of the Study:

• To evaluate the efficacy of the zebrafish embryo assay for in vivo nanotoxicity screening in the field of nanomedicine.
• To demonstrate that the zebrafish embryo assay can provide informative and efficient toxicity data for various nanomaterials.
• To establish the zebrafish embryo assay as a valuable tool for assessing the safety of nanoparticles used in biomedical applications.

Main Methods:

• Utilized prototypic polymeric drug carriers, gold-based nanodiagnostics/therapeutics, and iron oxide-based nanodiagnostics for testing.
• Employed the zebrafish (Danio rerio) embryo assay for in vivo nanotoxicity screening.
• Compared the results with traditional cell-based toxicity testing.

Main Results:

• The zebrafish embryo assay proved to be an easy, efficient, and informative method for nanotoxicity testing.
• The assay's findings accurately reflected cell-based toxicity data while offering additional insights.
• The system allows for semi-high-throughput analysis in a complex biological system.

Conclusions:

• The zebrafish embryo assay is a powerful tool for in vivo nanotoxicity screening, bridging the gap between cell-based and animal studies.
• This method is expected to become a popular choice for evaluating the safety of nanoparticles in nanomedicine.
• The assay offers a more complex yet less invasive and expensive alternative for nanotoxicity assessment.